Evidence map›Paper›PMID 32959675›Full record

SynthesisCartilage2021

Knee Intraosseous Injections: A Systematic Review of Clinical Evidence of Different Treatment Alternatives.

Berardo Di Matteo, Alberto Polignano, Francesco Onorato, Agostino La Porta, Francesco Iacono, Tommaso Bonanzinga, Giovanni Raspugli, Maurilio Marcacci, Elizaveta Kon

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Cartilage, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Combined subchondral and intra-articular injections of bone marrow aspirate concentrate provide stable results up to 24 months.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Berardo Di MatteoFirst Moscow State Medical University-Sechenov University, Moscow, Russia.ORCID 0000-0002-9807-0271
Alberto PolignanoHumanitas University, Department of Biomedical Sciences, Milan, Italy.
Francesco OnoratoHumanitas University, Department of Biomedical Sciences, Milan, Italy.ORCID 0000-0002-2738-0360
Agostino La PortaHumanitas University, Department of Biomedical Sciences, Milan, Italy.
Francesco IaconoHumanitas University, Department of Biomedical Sciences, Milan, Italy.
Tommaso BonanzingaHumanitas University, Department of Biomedical Sciences, Milan, Italy.
Giovanni RaspugliHumanitas University, Department of Biomedical Sciences, Milan, Italy.
Maurilio MarcacciHumanitas University, Department of Biomedical Sciences, Milan, Italy.
Elizaveta KonHumanitas University, Department of Biomedical Sciences, Milan, Italy.
Humanitas University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo systematically review the available clinical evidence regarding the safety and efficacy of knee intraosseous injections for the treatment of bone marrow lesions in patients affected by knee osteoarthritis.

designA literature search was carried out on PubMed, Embase, and Google Scholar databases in January 2020. The following inclusion criteria were adopted: (1) studies of any level of evidence, dealing with subchondral injection of bone substitute materials and/or biologic agents; (2) studies with minimum 5 patients treated; and (3) studies with at least 6 months' follow-up evaluation. All relevant data concerning clinical outcomes, adverse events, and rate of conversion to arthroplasty were extracted.

resultsA total of 12 studies were identified: 7 dealt with calcium phosphate administration, 3 with platelet-rich plasma, and 2 with bone marrow concentrate injection. Only 2 studies were randomized controlled trials, whereas 6 studies were prospective and the remaining 4 were retrospective. Studies included a total of 459 patients treated with intraosseous injections. Overall, only a few patients experienced adverse events and clinical improvement was documented in the majority of trial. The lack of any comparative evaluation versus subchondral drilling alone is the main limitation of the available evidence.

conclusionsKnee intraosseous injections are a minimally invasive and safe procedure to address subchondral bone damage in osteoarthritic patients. They are able to provide beneficial effects at short-term evaluation. More high-quality evidence is needed to confirm their potential and to identify the best product to adopt in clinical practice.

Indexed as

Platelet-Rich PlasmaBone SubstitutesCalcium PhosphatesHumansInjections, Intra-ArticularOsteoarthritis, KneeTreatment OutcomeBone SubstitutesCalcium Phosphatesbone marrow concentratebone marrow edemabone marrow lesionbone substitutesintraosseous injectionmesenchymal stem cellsosteoarthritisplatelet-rich plasma (PRP)subchondroplastytricalcium phosphate

Identifiers

PMID32959675
PMCPMC8808871
OpenAlexW3087633543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.